/bd/41/bb815f3e4010679c111a4c4bac8f.png "TESTERA SARS-CoV-2/FluA/FluB+ADV/RSV Antigēna Noteikšanas test, 1 pcs.")
SARS-CoV-2/FluA/FluB+ADV/RSV Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography-based, one-step in vitro test.
It is designed for the qualitative detection of SARS-CoV-2 virus, Influenza A virus, Influenza B virus, Adenovirus and Respiratory syncytial virus (RSV) in human anterior nasal swab samples.
The test results are used as an aid in the diagnosis of respiratory pathogen infections and are suitable for people with clinical symptoms such as fever, sore throat, cough or runny nose.
The test kit is designed for use as a self-test. It can be used independently by individuals aged 18 or older; for those under 18, it should be performed or supervised by an adult.
The kit is not used in combination with other equipment and is not automated.
SARS-CoV-2/FluA/FluB+ADV/RSV Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography-based, one-step in vitro test.
It is designed for the qualitative detection of SARS-CoV-2 virus, Influenza A virus, Influenza B virus, Adenovirus and Respiratory syncytial virus (RSV) in human anterior nasal swab samples.
The test results are used as an aid in the diagnosis of respiratory pathogen infections and are suitable for people with clinical symptoms such as fever, sore throat, cough or runny nose.
The test kit is designed for use as a self-test. It can be used independently by individuals aged 18 or older; for those under 18, it should be performed or supervised by an adult.
The kit is not used in combination with other equipment and is not automated.